ORM-10921

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameORM-10921
Drug Alias NameORM-10921
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2c adrenergic receptor antagonists
TargetsAlpha-2c adrenergic receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrion Corp
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A